Viking Therapeutics Inc (VKTX · NASDAQ)
VKTX · MARKET VIEW
Market view · as of Aug 10, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-1.10
vs $-1.21 est · beat
52-wk position
58.7%
-18.7% vs 52w high · -11.8% 1mo
Price (last ~year)
Viking Therapeutics (VKTX) recently expanded its funding flexibility through new equity offerings following a $132.6 million operating loss in the second quarter of 2026. The clinical-stage biopharmaceutical company, which focuses on metabolic and endocrine disorders, holds $125.8 million in cash against $4.1 million in debt with $0 in revenue. Shares closed at $34.26, below the average analyst target of $92.92.
Valuation
- Market cap
- $4.00B
- PEG
- -0.03
- P/B
- 9.79
- EV/EBITDA
- -71.64
- Beta
- 0.685
- Analyst target
- $92.92
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -88.8%
- ROA
- -51.9%
Price movement
- Last
- $34.26
- 1-month
- -11.8%
- 3-month
- +9.4%
- RSI (14)
- 40
- vs SMA200
- +1.4%
- 52-wk position
- 58.7% -18.7% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $0 | $-132.6M | $-128.0M | $-127.9M |
| 2026-03-31 | $0 | $-164.1M | $-158.3M | $-158.3M |
| 2025-12-31 | $0 | $-164.7M | $-157.7M | $-157.6M |
| 2025-09-30 | $0 | $-98.6M | $-90.8M | $-90.7M |
Recent news
- Neutral Viking Therapeutics (VKTX) Raises Fresh Capital After Wider Losses, Is It Still Undervalued? · 2026-08-08
- Neutral Viking Therapeutics (VKTX) Raises Fresh Capital After Wider Losses, Is It Still Undervalued? · 2026-08-07
- Somewhat-Bullish Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages · 2026-08-06
- Somewhat-Bullish Viking Therapeutics, Inc. (VKTX) Stock Price, News, Quote & History · 2026-08-05
- Neutral Does Viking’s Expanded Shelf and ATM Funding Shift the Bull Case For Viking Therapeutics (VKTX)? · 2026-08-04
- Neutral Does Viking’s Expanded Shelf and ATM Funding Shift the Bull Case For Viking Therapeutics (VKTX)? · 2026-08-04
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)